&nbsp;

dapColorectalJuly18.html

Jul 2018

Document

dapLungJuly18.xml

Jul 2018

Document

dapLungJuly18.html

Jul 2018

Document

dapProstateJuly18.xml

Jul 2018

Document

dapProstateJuly18.html

Jul 2018

Regimen

GEMC(RT)

Cancer Type:

Genitourinary,

Bladder / Urothelial

Intent: Adjuvant, Curative

Drugs Used:

gemcitabine

Quick Link(s):

Regimen Monograph

May 2019

Regimen

DURV

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation

Drugs Used:

durvalumab

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

DENO

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

denosumab (Unfunded)

Quick Link(s):

Regimen Monograph

Aug 2024

Document

Dr. Debra Bournes

Nov 2018

Guidelines and Advice

Gallium-68 PET Imaging in Neuroendocrine Tumours

Status: Current
ID: PET 19
Version: n/a

Nov 2018

Guidelines and Advice

Guidelines on Management of Dyspnea (Breathlessness) in Patients with Cancer

Status: Current
ID: ES SMG-3

Jan 2019

Regimen

DABRTRAM

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant, Curative

Funding:

Exceptional Access Program

daBRAfenib - For the adjuvant treatment of resected Stage III cutaneous melanoma according to clinical criteria

Exceptional Access Program

trametinib - For the adjuvant treatment of resected Stage III cutaneous melanoma according to clinical criteria

Drugs Used:

daBRAFenib,

trametinib